Patients using GLP-1 agonists had a significantly lower hysterectomy rate over 2-year and 5-year follow-up. Women with ...

The MHRA has advised that healthcare professionals remain vigilant for symptoms of acute pancreatitis, which may be ...

Can adding a GLP-1 to standard progestin therapy for nonmalignant uterine conditions lower women’s risk of developing endometrial cancer?

The production of GLP-1-based weight loss drugs releases huge amounts of organic solvents and other plastic byproducts that ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining ...

As GLP-1 weight-loss drugs soar in popularity, the list of unfortunate side effects that accompany them grows longer. Among ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

In a real-world study, patients with psoriatic disease treated with an IL-17 targeted biologic and a GLP-1 agonist experienced improvements in their quality of life.

In this cohort study of women with benign uterine pathology or endometrial hyperplasia, combined glucagon-like peptide-1 receptor ...

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the ...

Anti-doping group includes novel diabetes, weight-loss drugs in its monitoring program ...

GLP 1 receptor agonists were associated with higher incident chronic cough in adults with type 2 diabetes, with risk persisting even after excluding patients with reflux diagnoses.